Soffer SZ - Search Results

1

Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.

Soffer SZ, Moore JT, Kim E, Huang J, Yokoi A, Manley C, O'Toole K, Stolar C, Middlesworth W, Yamashiro DJ, Kandel JJ. Soffer SZ, et al. J Pediatr Surg. 2001 Aug;36(8):1177-81. doi: 10.1053/jpsu.2001.25747. J Pediatr Surg. 2001. PMID: 11479851

2

Distinct response of experimental neuroblastoma to combination antiangiogenic strategies.

Kim ES, Soffer SZ, Huang J, McCrudden KW, Yokoi A, Manley CA, Middlesworth W, Kandel JJ, Yamashiro DJ. Kim ES, et al. Among authors: soffer sz. J Pediatr Surg. 2002 Mar;37(3):518-22. doi: 10.1053/jpsu.2002.30855. J Pediatr Surg. 2002. PMID: 11877680

3

p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.

Huang J, Soffer SZ, Kim ES, Yokoi A, Moore JT, McCrudden KW, Manley C, Middlesworth W, O'Toole K, Stolar C, Yamashiro DJ, Kandel JJ. Huang J, et al. Among authors: soffer sz. J Pediatr Surg. 2002 Mar;37(3):523-7. doi: 10.1053/jpsu.2002.30858. J Pediatr Surg. 2002. PMID: 11877681

4

Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts.

Soffer SZ, Kim E, Huang J, McCrudden K, Yokoi A, Moore JT, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro DJ, Kandel JJ. Soffer SZ, et al. J Pediatr Surg. 2002 Mar;37(3):528-32. doi: 10.1053/jpsu.2002.30859. J Pediatr Surg. 2002. PMID: 11877682

5

Topotecan is anti-angiogenic in experimental hepatoblastoma.

McCrudden KW, Yokoi A, Thosani A, Soffer SZ, Kim ES, Huang J, Manley C, O'toole K, Yamashiro DJ, Kandel JJ, Middlesworth W. McCrudden KW, et al. Among authors: soffer sz. J Pediatr Surg. 2002 Jun;37(6):857-61. doi: 10.1053/jpsu.2002.32887. J Pediatr Surg. 2002. PMID: 12037749

6

Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma.

Kim ES, Serur A, Huang J, Manley CA, McCrudden KW, Frischer JS, Soffer SZ, Ring L, New T, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ. Kim ES, et al. Among authors: soffer sz. Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11399-404. doi: 10.1073/pnas.172398399. Epub 2002 Aug 12. Proc Natl Acad Sci U S A. 2002. PMID: 12177446 Free PMC article.

7

Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor.

Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'Toole K, Yamashiro DJ, Kandel JJ. Yokoi A, et al. Among authors: soffer sz. Oncol Rep. 2003 Sep-Oct;10(5):1271-4. Oncol Rep. 2003. PMID: 12883692

8

Human epidermal growth factor receptor signaling contributes to tumor growth via angiogenesis in her2/neu-expressing experimental Wilms' tumor.

Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'toole K, Yamashiro DJ, Kandel JJ. Yokoi A, et al. Among authors: soffer sz. J Pediatr Surg. 2003 Nov;38(11):1569-73. doi: 10.1016/s0022-3468(03)00562-1. J Pediatr Surg. 2003. PMID: 14614702

9

Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.

Huang J, Soffer SZ, Kim ES, McCrudden KW, Huang J, New T, Manley CA, Middlesworth W, O'Toole K, Yamashiro DJ, Kandel JJ. Huang J, et al. Among authors: soffer sz. Mol Cancer Res. 2004 Jan;2(1):36-42. Mol Cancer Res. 2004. PMID: 14757844

10

Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.

Soffer SZ, Kim E, Moore JT, Huang J, Yokoi A, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro D, Kandel J. Soffer SZ, et al. J Pediatr Surg. 2001 Dec;36(12):1781-4. doi: 10.1053/jpsu.2001.28823. J Pediatr Surg. 2001. PMID: 11733906

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page